Abstract
Purpose of Review
Recurrent meningitis is a rare clinical scenario that can be self-limiting or life threatening depending on the underlying etiology. This review describes the causes, risk factors, treatment, and prognosis for recurrent meningitis. As a general overview of a broad topic, the aim of this review is to provide clinicians with a comprehensive differential diagnosis to aide in the evaluation and management of a patient with recurrent meningitis.
Recent Findings
New developments related to understanding the pathophysiology of recurrent meningitis are as scarce as studies evaluating the treatment and prevention of this rare disorder. A trial evaluating oral valacyclovir suppression after HSV-2 meningitis did not demonstrate a benefit in preventing recurrences. The data on prophylactic antibiotics after basilar skull fractures do not support their use. Intrathecal trastuzumab has shown promise in treating leptomeningeal carcinomatosis from HER-2 positive breast cancer. Monoclonal antibodies used to treat cancer and autoimmune diseases are new potential causes of drug-induced aseptic meningitis.
Summary
Despite their potential for causing recurrent meningitis, the clinical entities reviewed herein are not frequently discussed together given that they are a heterogeneous collection of unrelated, rare diseases. Epidemiologic data on recurrent meningitis are lacking. The syndrome of recurrent benign lymphocytic meningitis described by Mollaret in 1944 was later found to be closely related to HSV-2 reactivation, but HSV-2 is by no means the only etiology of recurrent aseptic meningitis. While the mainstay of treatment for recurrent meningitis is supportive care, it is paramount to ensure that reversible and treatable causes have been addressed for further prevention.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Gilden DH, Mahalingam R, Cohrs RJ, Tyler KL. Herpesvirus infections of the nervous system. Nat Clin Pract Neurol. 2007;3(2):82–94.
Jarrin I, Sellier P, Lopes A, Morgand M, Makovec T, Delcey V, et al. Etiologies and management of aseptic meningitis in patients admitted to an internal medicine department. Medicine (Baltimore). 2016;95(2):e2372.
Parisi SG, Basso M, Del Vecchio C, Andreis S, Franchin E, Dal Bello F, et al. Viral infections of the central nervous system in elderly patients: a retrospective study. Int J Infect Dis. 2016;44:8–10.
Gnann JW Jr, Skoldenberg B, Hart J, Aurelius E, Schliamser S, Studahl M, et al. Herpes simplex encephalitis: lack of clinical benefit of long-term valacyclovir therapy. Clin Infect Dis. 2015;61(5):683–91.
Shalabi M, Whitley RJ. Recurrent benign lymphocytic meningitis. Clin Infect Dis. 2006;43(9):1194–7.
Yamamoto LJ, Tedder DG, Ashley R, Levin MJ. Herpes simplex virus type 1 DNA in cerebrospinal fluid of a patient with Mollaret’s meningitis. N Engl J Med. 1991;325(15):1082–5.
• Mollaret P, et al. Rev Neurol (Paris). 1944;76:57–76. The landmark paper by Pierre Mollaret, in which he describes the clinical presentation and CSF analysis of three patients with recurrent aseptic meningitis
Chan TY, Parwani AV, Levi AW, Ali SZ. Mollaret’s meningitis: cytopathologic analysis of fourteen cases. Diagn Cytopathol. 2003;28(5):227–31.
Acosta AM, Antoon JW, Kempe M, Ahmad S, Groth J, Valyi-Nagy T, et al. Tracing the footprints: a case of chronic meningitis with unusual mononuclear cells in the cerebrospinal fluid. Diagn Cytopathol 2017 11.
Poulikakos PJ, Sergi EE, Margaritis AS, Kioumourtzis AG, Kanellopoulos GD, Mallios PK, et al. A case of recurrent benign lymphocytic (Mollaret’s) meningitis and review of the literature. J Infect Public Health. 2010;3(4):192–5.
Bruyn GW, Straathof LJ, Raymakers GM. Mollaret’s meningitis. Differential diagnosis and diagnostic pitfalls. Neurology. 1962;12:745–53.
Tyler KL. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret’s. Herpesviridae. 2004;11(Suppl 2):57A–64A.
Tedder DG, Ashley R, Tyler KL, Levin MJ. Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med. 1994;121(5):334–8.
Davis LE, Guerre J, Gerstein WH. Recurrent herpes simplex virus type 2 meningitis in elderly persons. Arch Neurol. 2010;67(6):759–60.
Kallio-Laine K, Seppanen M, Kautiainen H, Lokki ML, Lappalainen M, Valtonen V, et al. Recurrent lymphocytic meningitis positive for herpes simplex virus type 2. Emerg Infect Dis. 2009;15(7):1119–22.
Franzen-Rohl E, Schepis D, Lagrelius M, Franck K, Jones P, Liljeqvist JA, et al. Increased cell-mediated immune responses in patients with recurrent herpes simplex virus type 2 meningitis. Clin Vaccine Immunol. 2011;18(4):655–60.
Miller S, Mateen FJ, Aksamit AJ Jr. Herpes simplex virus 2 meningitis: a retrospective cohort study. J Neuro-Oncol. 2013;19(2):166–71.
• Hermans PE, Goldstein NP, Wellman WE. Mollaret’s meningitis and differential diagnosis of recurrent meningitis. Report of case, with review of the literature. Am J Med. 1972;52(1):128–40. One of the earliest comprehensive review articles on recurrent meningitis
• Aurelius E, Franzen-Rohl E, Glimaker M, Akre O, Grillner L, Jorup-Ronstrom C, et al. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial. Clin Infect Dis. 2012;54(9):1304–13. The first prospective study of antiviral medication to prevent recurrent HSV-2 meningitis
Janocha-Litwin J, Simon K. Recurrent meningitis—a review of current literature. Przegl Epidemiol. 2013;67(1):41–5.
• Tebruegge M, Curtis N. Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis. Clin Microbiol Rev. 2008;21(3):519–37. A comprehensive review of recurrent bacterial meningitis
Eljamel MS, Foy PM. Acute traumatic CSF fistulae: the risk of intracranial infection. Br J Neurosurg. 1990;4(5):381–5.
• Chen JX, Alkire BC, Lam AC, Curry WT, Holbrook EH. Aseptic meningitis with craniopharyngioma resection: consideration after endoscopic surgery. J Neurol Surg Rep. 2016;77(4):e151–5. A case report and review of the literature on aseptic meningitis after craniopharyngioma resection
Muzzi E, Battelino S, Gregori M, Pellegrin A, Orzan E. Life-threatening unilateral hearing impairments. Review of the literature on the association between inner ear. Malformations and meningitis. Int J Pediatr Otorhinolaryngol. 2015;79(12):1969–74.
Adriani KS, Brouwer MC, van de Beek D. Risk factors for community-acquired bacterial meningitis in adults. Neth J Med. 2015;73(2):53–60.
Adriani KS, van de Beek D, Brouwer MC, Spanjaard L, de Gans J. Community-acquired recurrent bacterial meningitis in adults. Clin Infect Dis. 2007;45(5):e46–51.
Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993;328(1):21–8.
Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61(40):816–9.
Hernandez-Trujillo HS, Chapel H, Lo Re V 3rd, Notarangelo LD, Gathmann B, Grimbacher B, et al. Comparison of American and European practices in the management of patients with primary immunodeficiencies. Clin Exp Immunol. 2012;169(1):57–69.
Ratilal BO, Costa J, Pappamikail L, Sampaio C. Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures. Cochrane Database Syst Rev 2015;(4):CD004884.
Villalobos T, Arango C, Kubilis P, Rathore M. Antibiotic prophylaxis after basilar skull fractures: a meta-analysis. Clin Infect Dis. 1998;27(2):364–9.
Cho TA, Venna N. Management of acute, recurrent, and chronic meningitides in adults. Neurol Clin. 2010;28(4):1061–88.
Jhamb R, Kashyap B, Das S, Berry N, Garg A. Symptomatic relapse of HIV-associated cryptococcal meningitis: recurrent cryptococcal meningitis or Cryptococcus-related immune reconstitution inflammatory syndrome? Int J STD AIDS. 2014;25(5):369–72.
Ginsberg L, Kidd D. Chronic and recurrent meningitis. Pract Neurol. 2008;8(6):348–61.
Zammarchi L, Montagnani F, Tordini G, Gotuzzo E, Bisoffi Z, Bartoloni A, et al. Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive peruvian migrant resettled in Italy. AmJTrop Med Hyg. 2015;92(6):1257–60.
Prandota J, Gryglas A, Fuglewicz A, Zeslawska-Falenczyk A, Ujma-Czapska B, Szenborn L, et al. Recurrent headaches may be caused by cerebral toxoplasmosis. World J Clin Pediatr. 2014;3(3):59–68.
Pavlidis N. The diagnostic and therapeutic management of leptomeningeal carcinomatosis. Ann Oncol. 2004;15(Suppl 4):iv285–91.
• Le Rhun E, Galanis E. Leptomeningeal metastases of solid cancer. Curr Opin Neurol. 2016;29(6):797–805. A comprehensive review of leptomenigneal metastasis in solid cancer
Chamberlain MC, Nolan C, Abrey LE. Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. J Neuro-Oncol. 2005;75(1):71–83.
Le Rhun E, Taillibert S, Chamberlain MC. Carcinomatous meningitis: leptomeningeal metastases in solid tumors. Surg Neurol Int. 2013;4(Suppl 4):S265–88.
Kak M, Nanda R, Ramsdale EE, Lukas RV. Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities. J Clin Neurosci. 2015;22(4):632–7.
Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol. 2013;70(3):311–9.
Galati D, Di Noto R, Del Vecchio L. Diagnostic strategies to investigate cerebrospinal fluid involvement in haematological malignancies. Leuk Res. 2013;37(3):231–7.
• Lu NT, Raizer J, Gabor EP, Liu NM, Vu JQ, Slamon DJ, et al. Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient. J Immunother Cancer. 2015;15(3):41. A case report of intrathecal trastuzumab benefiting a patient with leptomeningeal spread of HER-2+ breast cancer
• Wesley SF, Garcia-Santibanez R, Liang J, Pyburn D. Incidence of meningeal enhancement on brain MRI secondary to lumbar puncture. Neurology: Clinical Practice. 2016;6(4):315–20. A single center retrospective study of meningeal enhancement after lumbar puncture
Jane JA Jr, Laws ER. Craniopharyngioma. Pituitary. 2006;9(4):323–6.
Khan RB, Merchant TE, Boop FA, Sanford RA, Ledet D, Onar-Thomas A, et al. Headaches in children with craniopharyngioma. J Child Neurol. 2013;28(12):1622–5.
Hadden D, Allen I. Chemical meningitis due to rupture of a craniopharyngioma cyst. J R Soc Med. 2004;97(12):585–6.
Krueger DW, Larson EB. Recurrent fever of unknown origin, coma, and meningismus due to a leaking craniopharyngioma. Am J Med. 1988;84(3 Pt 1):543–5.
Patnaik A, Mahapatra AK, Sarkar S, Samal DK. Spontaneous leaking craniopharyngioma causing preoperative chemical meningitis. Surg Neurol Int. 2016;7:41.
Achard JM, Lallement PY, Veyssier P. Recurrent aseptic meningitis secondary to intracranial epidermoid cyst and Mollaret’s meningitis: two distinct entities or a single disease? A case report and a nosologic discussion. Am J Med. 1990;89(6):807–10.
Cherian A, Baheti NN, Easwar HV, Nair DS, Iype T. Recurrent meningitis due to epidermoid. J Pediatr Neurosci. 2012;7(1):47–8.
Park JC, Chung CK, Kim HJ. Iatrogenic spinal epidermoid tumor. A complication of spinal puncture in an adult. Clin Neurol Neurosurg. 2003;105(4):281–5.
Velamati R, Hageman JR, Bartlett A. Meningitis secondary to ruptured epidermoid cyst: case-based review. Pediatr Ann. 2013;42(6):248–51.
Per H, Kumandas S, Gumus H, Yikilmaz A, Kurtsoy A. Iatrogenic epidermoid tumor: late complication of lumbar puncture. J Child Neurol. 2007;22(3):332–6.
Rodriguez SC, Olguin AM, Miralles CP, Viladrich PF. Characteristics of meningitis caused by ibuprofen: report of 2 cases with recurrent episodes and review of the literature. Medicine (Baltimore). 2006;85(4):214–20.
Lee RZ, Hardiman O, O'Connell PG. Ibuprofen-induced aseptic meningoencephalitis. Rheumatology (Oxford). 2002;41(3):353–5.
Karmacharya P, Mainali NR, Aryal MR, Lloyd B. Recurrent case of ibuprofen-induced aseptic meningitis in mixed connective tissue disease. BMJ Case Rep. 2013;2013 doi:10.1136/bcr-2013-009571.
Ginsberg L. Difficult and recurrent meningitis. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 1):i16–21.
Simms KM, Kortepeter C, Avigan M. Lamotrigine and aseptic meningitis. Neurology. 2012;78(12):921–7.
Jolles S, Sewell WA, Leighton C. Drug-induced aseptic meningitis: diagnosis and management. Drug Saf. 2000;22(3):215–26.
Holle D, Obermann M. Headache in drug-induced aseptic meningitis. Curr Pain Headache Rep. 2015;19(7):29.
Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Goncalves O, et al. Behcet’s disease—a contemporary review. J Autoimmun. 2009;32(3–4):178–88.
Al-Araji A, Kidd DP. Neuro-Behcet’s disease: epidemiology, clinical characteristics, and management. Lancet Neurol. 2009;8(2):192–204. A comprehensive literature review of neuro-Behcet’s disease, including aseptic meningitis
Benjilali L, Harmouche H, El Bied S, Raffali J, Tazi Mezalek Z, Adnaoui M, et al. Recurrent meningitis revealing a Behcet’s disease. Rheumatol Int. 2008;29(1):91–3.
Appenzeller S, Kobayashi E, Costallat LT, Zanardi VD, Ribeiro Neto JM, Damasceno BP, et al. Magnetic resonance imaging in the evaluation of patients with aseptic.
Mikdashi J, Kennedy S, Krumholz A. Recurrent benign lymphocytic (mollaret) meningitis in systemic lupus erythematosus. Neurologist. 2008;14(1):43–5.
Canoso JJ, Cohen AS. Aseptic meningitis in systemic lupus erythematosus. Report of three cases. Arthritis Rheum. 1975;18(4):369–74.
Welsby P, Smith C. Recurrent sterile meningitis as a manifestation of systemic lupus erythematosis. Scand J Infect Dis. 1977;9(2):149–50.
Finelli PF, Yockey CC, Herbert AJ Jr. Recurrent aseptic meningitis in an elderly man. Unusual prodrome of systemic lupus erythematosus. JAMA. 1976;235(11):1142–3.
Dong J, Suwanvecho S, Chen L, Keung YK. Initial presentation of systemic lupus erythematosus masquerading as bacterial meningitis. J Am Board Fam Pract. 2001;14(6):470–3.
Ishida K, Uchihara T, Mizusawa H. Recurrent aseptic meningitis: a new CSF complication of Sjogren’s syndrome. J Neurol. 2007;254(6):806–7.
Morreale M, Marchione P, Giacomini P, Pontecorvo S, Marianetti M, Vento C, et al. Neurological involvement in primary Sjogren syndrome: a focus on central nervous system. PLoS One. 2014;9(1):e84605.
Alexander EL, Alexander GE. Aseptic meningoencephalitis in primary Sjogren’s syndrome. Neurology. 1983;33(5):593–8.
Tavee JO, Stern BJ. Neurosarcoidosis. Continuum (Minneap Minn). 2014;20(3 Neurology of Systemic Disease):545–59.
Gullapalli D, Phillips LH 2nd. Neurologic manifestations of sarcoidosis. Neurol Clin. 2002;20(1):59–83.
Kalra S, Silman A, Akman-Demir G, Bohlega S, Borhani-Haghighi A, Constantinescu CS, et al. Diagnosis and management of neuro-Behcet’s disease: international consensus recommendations. J Neurol. 2014;261(9):1662–76.
Rossi R, Valeria SM. Subacute aseptic meningitis as neurological manifestation of primary Sjogren’s syndrome. Clin Neurol Neurosurg. 2006;108(7):688–91.
Allegri P, Rissotto R, Herbort CP, Murialdo U. CNS diseases and uveitis. J Ophthalmic Vis Res. 2011;6(4):284–308.
Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin. 2006;46(2):111–22.
Filina T, Feja KN, Tolan RW Jr. An adolescent with pseudomigraine, transient headache, neurological deficits, and lymphocytic pleocytosis (HaNDL syndrome): case report and review of the literature. Clin Pediatr (Phila). 2013;52(6):496–502.
Pascual J, Valle N. Pseudomigraine with lymphocytic pleocytosis. Curr Pain Headache Rep. 2003;7(3):224–8.
Stelten BM, Venhovens J, van der Velden LB, Meulstee J, Verhagen WI. Syndrome of transient headache and neurological deficits with cerebrospinal fluid lymphocytosis (HaNDL): a case report with serial electroencephalography (EEG) recordings. Is there an association with human herpes virus type 7 (HHV-7) infection? Cephalalgia 2015 17.
Toth CC. Persistent cerebrospinal fluid abnormalities in the syndrome of headache, neurological deficit, and cerebrospinal fluid lymphocytosis despite resolution of clinical symptomatology. Headache. 2002;42(10):1038–43.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Jon Rosenberg and Benjamin T. Galen declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Secondary Headache
Rights and permissions
About this article
Cite this article
Rosenberg, J., Galen, B.T. Recurrent Meningitis. Curr Pain Headache Rep 21, 33 (2017). https://doi.org/10.1007/s11916-017-0635-7
Published:
DOI: https://doi.org/10.1007/s11916-017-0635-7